GENEVA: The head of the World Trade Organization (WTO) told Reuters on Thursday that negotiations on an intellectual property deal for Covid-19 vaccines were ongoing between the four parties, saying they were seeking to agree on the proposal’s final terms.
Since the draft compromise emerged in the media a month ago, pressure from civil society groups has been rising for the parties – the United States, the European Union, India and South Africa – to walk away from the deal.
Other public figures have also criticised it such as German Chancellor Olaf Scholz and former UN Secretary-General Ban Ki-moon, saying it is too narrowly focused on vaccines. read more
“People are saying the text is now being rejected. It is not true,” director-general Ngozi Okonjo-Iweala told Reuters by telephone. “They are still trying to iron out the last things. It’s just the last few tweaks,” she said, without elaborating.
Okonjo-Iweala, who took over the top job a year ago with a mandate to reinvigorate the 27-year-old institution, has been brokering the talks for the past few months in an effort to break a more than year-long stalemate at the WTO. read more
India and South Africa, backed by dozens of other WTO members, had proposed a broad waiver of IP rights for Covid-19 drugs and vaccines, but failed to overcome opposition from members like Britain and Switzerland who argued that pharmaceutical research required such protections.
The compromise proposal that Okonjo-Iweala referred to, if finalised among the four negotiators, still needs to be presented to all 164 WTO members which each hold a veto.
No date has yet been fixed for that meeting.
Okonjo-Iweala said in the same interview that she plans to meet US Trade Representative Katherine Tai next week to discuss a ministerial trade conference at the WTO’s Geneva headquarters in June and to brief US Congress.
Since the draft compromise emerged in the media a month ago, pressure from civil society groups has been rising for the parties – the United States, the European Union, India and South Africa – to walk away from the deal.
Other public figures have also criticised it such as German Chancellor Olaf Scholz and former UN Secretary-General Ban Ki-moon, saying it is too narrowly focused on vaccines. read more
“People are saying the text is now being rejected. It is not true,” director-general Ngozi Okonjo-Iweala told Reuters by telephone. “They are still trying to iron out the last things. It’s just the last few tweaks,” she said, without elaborating.
Okonjo-Iweala, who took over the top job a year ago with a mandate to reinvigorate the 27-year-old institution, has been brokering the talks for the past few months in an effort to break a more than year-long stalemate at the WTO. read more
India and South Africa, backed by dozens of other WTO members, had proposed a broad waiver of IP rights for Covid-19 drugs and vaccines, but failed to overcome opposition from members like Britain and Switzerland who argued that pharmaceutical research required such protections.
The compromise proposal that Okonjo-Iweala referred to, if finalised among the four negotiators, still needs to be presented to all 164 WTO members which each hold a veto.
No date has yet been fixed for that meeting.
Okonjo-Iweala said in the same interview that she plans to meet US Trade Representative Katherine Tai next week to discuss a ministerial trade conference at the WTO’s Geneva headquarters in June and to brief US Congress.
For all the latest business News Click Here
Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
